Literature DB >> 21546441

Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure.

Neal L Benowitz1, Katherine M Dains, Delia Dempsey, Margaret Wilson, Peyton Jacob.   

Abstract

INTRODUCTION: Black smokers are reported to have higher lung cancer rates and greater tobacco dependence at lower levels of cigarette consumption compared to non-Hispanic White smokers. We studied the relationship between cigarettes per day (CPD) and biomarkers of nicotine and carcinogen exposure in Black and White smokers.
METHODS: In 128 Black and White smokers, we measured plasma nicotine and its main proximate metabolite cotinine, urine nicotine equivalents, 4-(methylnitrosamino)-1-(3)pyridyl-1-butanol (NNAL), and polycyclic aromatic hydrocarbon (PAH) metabolites.
RESULTS: The dose-response between CPD and nicotine equivalents, and NNAL and PAH was flat for Black but positive for White smokers (Race × CPD interaction, all ps < .05). Regression estimates for the Race × CPD interactions were 0.042 (95% CI 0.013-0.070), 0.054 (0.023-0.086), and 0.028 (0.004-0.052) for urine nicotine equivalents, NNAL, and PAHs, respectively. In contrast there was a strong correlation between nicotine equivalents and NNAL and PAH independent of race. Nicotine and carcinogen exposure per individual cigarette was inversely related to CPD. This inverse correlation was stronger in Black compared to White smokers and stronger in menthol compared to regular cigarette smokers (not mutually adjusted).
CONCLUSIONS: Our data indicate that Blacks on average smoke cigarettes differently than White smokers such that CPD predicts smoke intake more poorly in Black than in White smokers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21546441      PMCID: PMC3168241          DOI: 10.1093/ntr/ntr072

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  40 in total

1.  Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.

Authors:  Delia Dempsey; Piotr Tutka; Peyton Jacob; Faith Allen; Kerri Schoedel; Rachel F Tyndale; Neal L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2004-07       Impact factor: 6.875

2.  Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry.

Authors:  Peyton Jacob; Margaret Wilson; Neal L Benowitz
Journal:  Anal Chem       Date:  2007-01-15       Impact factor: 6.986

3.  Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure.

Authors:  Assieh A Melikian; Mirjana V Djordjevic; Shuquan Chen; John Richie; Steven D Stellman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-07       Impact factor: 4.254

4.  Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers.

Authors:  Hans J Roethig; Sagar Munjal; Shixia Feng; Qiwei Liang; Mohamadi Sarkar; Ruediger-A Walk; Paul E Mendes
Journal:  Nicotine Tob Res       Date:  2009-08-21       Impact factor: 4.244

5.  Comparison of smoking-related risk factors among black and white males.

Authors:  T D Sterling; J J Weinkam
Journal:  Am J Ind Med       Date:  1989       Impact factor: 2.214

6.  Urine menthol as a biomarker of mentholated cigarette smoking.

Authors:  Neal L Benowitz; Katherine M Dains; Delia Dempsey; Christopher Havel; Margaret Wilson; Peyton Jacob
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-20       Impact factor: 4.254

7.  Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.

Authors:  P Jacob; L Yu; M Wilson; N L Benowitz
Journal:  Biol Mass Spectrom       Date:  1991-05

8.  The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristics.

Authors:  Jay H Lubin; Neil Caporaso; Dorothy K Hatsukami; Anne M Joseph; Stephen S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

9.  Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.

Authors:  S G Carmella; S A Akerkar; J P Richie; S S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995-09       Impact factor: 4.254

10.  Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry.

Authors:  Peyton Jacob; Christopher Havel; Do-Hoon Lee; Lisa Yu; Mark D Eisner; Neal L Benowitz
Journal:  Anal Chem       Date:  2008-10-08       Impact factor: 6.986

View more
  72 in total

1.  1,3-Butadiene exposure and metabolism among Japanese American, Native Hawaiian, and White smokers.

Authors:  Sungshim Lani Park; Srikanth Kotapati; Lynne R Wilkens; Maarit Tiirikainen; Sharon E Murphy; Natalia Tretyakova; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

2.  Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.

Authors:  Krista A Zanetti; Zhaoming Wang; Melinda Aldrich; Christopher I Amos; William J Blot; Elise D Bowman; Laurie Burdette; Qiuyin Cai; Neil Caporaso; Charles C Chung; Elizabeth M Gillanders; Christopher A Haiman; Helen M Hansen; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Shengchao Li; Lorna Haughton McNeill; Bríd M Ryan; Ann G Schwartz; Jennette D Sison; Margaret R Spitz; Margaret Tucker; Angela S Wenzlaff; John K Wiencke; Lynne Wilkens; Margaret R Wrensch; Xifeng Wu; Wei Zheng; Weiyin Zhou; David Christiani; Julie R Palmer; Trevor M Penning; Alyssa G Rieber; Lynn Rosenberg; Edward A Ruiz-Narvaez; Li Su; Anil Vachani; Yongyue Wei; Alexander S Whitehead; Stephen J Chanock; Curtis C Harris
Journal:  Lung Cancer       Date:  2016-05-13       Impact factor: 5.705

3.  Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer.

Authors:  Samir S Khariwala; Steven G Carmella; Irina Stepanov; Dipankar Bandyopadhyay; Heather H Nelson; Bevan Yueh; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Laryngoscope       Date:  2015-04-15       Impact factor: 3.325

4.  Effect of menthol on nicotine pharmacokinetics in rats after cigarette smoke inhalation.

Authors:  Cyril V Abobo; Jing Ma; Dong Liang
Journal:  Nicotine Tob Res       Date:  2012-02-06       Impact factor: 4.244

5.  A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine.

Authors:  Taraneh Taghavi; Maria Novalen; Caryn Lerman; Tony P George; Rachel F Tyndale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-05-31       Impact factor: 4.254

6.  Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop.

Authors:  Cindy M Chang; Selvin H Edwards; Aarthi Arab; Arseima Y Del Valle-Pinero; Ling Yang; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-11-09       Impact factor: 4.254

7.  CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations.

Authors:  Catherine A Wassenaar; Yuanqing Ye; Qiuyin Cai; Melinda C Aldrich; Joanne Knight; Margaret R Spitz; Xifeng Wu; William J Blot; Rachel F Tyndale
Journal:  Carcinogenesis       Date:  2014-11-21       Impact factor: 4.944

Review 8.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

9.  Diurnal Evening Type is Associated with Current Smoking, Nicotine Dependence and Nicotine Intake in the Population Based National FINRISK 2007 Study.

Authors:  Ulla Broms; Marjaana Pennanen; Kristiina Patja; Hanna Ollila; Tellervo Korhonen; Aino Kankaanpää; Ari Haukkala; Annamari Tuulio-Henriksson; Markku Koskenvuo; Erkki Kronholm; Tiina Laatikainen; Markku Peltonen; Timo Partonen; Jaakko Kaprio
Journal:  J Addict Res Ther       Date:  2012-01-25

10.  Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans.

Authors:  Deliang Tang; Oleksandr N Kryvenko; Yun Wang; Michelle Jankowski; Sheri Trudeau; Andrew Rundle; Benjamin A Rybicki
Journal:  Carcinogenesis       Date:  2012-10-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.